期刊文献+

瞬时弹性硬度测定在肝纤维化无创诊断中的应用进展 被引量:5

原文传递
导出
摘要 肝纤维化是肝脏损伤修复的结果 ,是各种慢性肝病发展为肝硬化、肝癌的必经阶段,在肝功能障碍和门静脉高压形成的发生与发展过程中具有重要作用,准确地评估肝纤维化的程度和进展情况对于各种肝病临床诊治至关重要。自从1923年开展以来,经皮肝脏穿刺活检组织检查(以下简称肝穿检查)被普遍地认为是诊断肝脏纤维化的'金标准'[1],
机构地区 解放军第
出处 《中华临床医师杂志(电子版)》 CAS 2010年第5期648-650,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献2

  • 1Tadashi Takeda,Takahiro Yasuda,Yuji Nakayama,Mika Nakaya,Megumi Kimura,Mariko Yamashita,Ayumi Sawada,Koji Abo,Setsuko Takeda,Hiroki Sakaguchi,Susumu Shiomi,Hitoshi Asai,Shuichi Seki.Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C[J].World Journal of Gastroenterology,2006,12(48):7768-7773. 被引量:16
  • 2Ryota Masuzaki,Ryosuke Tateishi,Haruhiko Yoshida,Takahisa Sato,Takamasa Ohki,Tadashi Goto,Hideo Yoshida,Shinpei Sato,Yosuke Sugioka,Hitoshi Ikeda,Shuichiro Shiina,Takao Kawabe,Masao Omata. Assessing liver tumor stiffness by transient elastography[J] 2007,Hepatology International(3):394~397

二级参考文献35

  • 1[1]Yoshida H,Shiratori Y,Moriyama M,Arakawa Y,Ide T,Sata M,Inoue O,Yano M,Tanaka M,Fujiyama S,Nishiguchi S,Kuroki T,Imazeki F,Yokosuka O,Kinoyama S,Yamada G,Omata M.Interferon therapy reduces the risk for hepatocellular carcinoma:national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.IHIT Study Group.Inhibition of Hepatocarcinogenesis by Interferon Therapy.Ann Intern Med 1999; 131:174-181
  • 2[2]Poynard T,McHutchison J,Davis GL,Esteban-Mur R,Goodman Z,Bedossa P,Albrecht J.Impact of interferon alfa2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.Hepatology 2000; 32:1131-1137
  • 3[3]Bravo AA,Sheth SG,Chopra S.Liver biopsy.N Engl J Med 2001; 344:495-500
  • 4[4]Cadranel JF,Rufat P,Degos F.Practices of liver biopsy in France:results of a prospective nationwide survey.For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).Hepatology 2000; 32:477-481
  • 5[5]Poynard T,Ratziu V,Bedossa P.Appropriateness of liver biopsy.Can J Gastroenterol 2000; 14:543-548
  • 6[6]Maharaj B,Maharaj RJ,Leary WP,Cooppan RM,Naran AD,Pirie D,Pudffin DJ.Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.Lancet 1986; 1:523-525
  • 7[7]Bedossa P,Dargere D,Paradis V.Sampling variability of liver fibrosis in chronic hepatitis C.Hepatology 2003; 38:1449-1457
  • 8[8]The French METAVIR Cooperative Study Group.Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C.The French METAVIR Cooperative Study Group.Hepatology 1994; 20:15-20
  • 9[9]Engstrom-Laurent A,Loof L,Nyberg A,Schroder T.Increased serum levels of hyaluronate in liver disease.Hepatology 1985; 5:638-642
  • 10[10]Niemela O,Risteli L,Sotaniemi EA,Risteli J.Type Ⅳ collagen and laminin-related antigens in human serum in alcoholic liver disease.Eur J Clin Invest 1985; 15:132-137

共引文献15

同被引文献52

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部